Search

Home > FierceBiotech Radio > Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand
Podcast: FierceBiotech Radio
Episode:

Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand
Category: Science & Medicine
Duration: 00:28:55
Publish Date: 2015-10-14 23:00:00
Description:

Fierce editors discuss a major blow to Eli Lilly's late-stage pipeline, Mylan's ongoing courtship of Perrigo, and Merck KGaA's big push to distance itself from that other Merck.
Total Play: 0